These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26832356)

  • 21. Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6.
    Kobayashi M; Chayama K; Arase Y; Tsubota A; Saitoh S; Suzuki Y; Kobayashi M; Ikeda K; Matsuda M; Koike H; Hashimoto M; Kumada H
    J Gastroenterol; 1999 Aug; 34(4):505-9. PubMed ID: 10452685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum.
    Schalasta G; Speicher A; Börner A; Enders M
    J Clin Microbiol; 2016 Apr; 54(4):1101-7. PubMed ID: 26865682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance evaluation of the VERSANT HCV RNA qualitative assay by using transcription-mediated amplification.
    Gorrin G; Friesenhahn M; Lin P; Sanders M; Pollner R; Eguchi B; Pham J; Roma G; Spidle J; Nicol S; Wong C; Bhade S; Comanor L
    J Clin Microbiol; 2003 Jan; 41(1):310-7. PubMed ID: 12517866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multi-center clinical study comparing Sansure Magb and CAP/CTM HBV tests in the quantitative detection of HBV DNA.
    Fu X; Tan D; Dou X; Chen J; Wu J
    J Infect Dev Ctries; 2016 Aug; 10(7):755-61. PubMed ID: 27482808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
    Nainan OV; Alter MJ; Kruszon-Moran D; Gao FX; Xia G; McQuillan G; Margolis HS
    Gastroenterology; 2006 Aug; 131(2):478-84. PubMed ID: 16890602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
    Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
    J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA.
    Sauné K; Abravanel F; Haslé C; Boineau J; Mengelle C; Izopet J
    J Clin Virol; 2016 Nov; 84():7-11. PubMed ID: 27636506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
    Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
    J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
    Konnick EQ; Williams SM; Ashwood ER; Hillyard DR
    J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum.
    Trimoulet P; Halfon P; Pohier E; Khiri H; Chêne G; Fleury H
    J Clin Microbiol; 2002 Jun; 40(6):2031-6. PubMed ID: 12037059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis C virus genotyping: comparison of the Abbott RealTime HCV Genotype II assay and NS5B sequencing].
    Vaghefi P; Marchadier E; Dussaix E; Roque-Afonso AM
    Pathol Biol (Paris); 2010 Apr; 58(2):175-8. PubMed ID: 19942365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pierce VM; Eversley JS; Tran TK; Rosenberg ES
    Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?
    Trimoulet P; Merchadou L; Winnock M; Loko MA; Fleury H; Salmon D; Dabis F; Neau D;
    J Virol Methods; 2012 Apr; 181(1):131-3. PubMed ID: 22285372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the QIAGEN artus HCV QS-RGQ test with the Roche COBAS Ampliprep/COBAS TaqMan HCV test v2.0 for the quantification of HCV-RNA in plasma samples.
    Schønning K
    J Clin Virol; 2014 Aug; 60(4):323-7. PubMed ID: 24894603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
    Gelderblom HC; Menting S; Beld MG
    Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA.
    Wolff D; Gerritzen A
    Clin Chem Lab Med; 2007; 45(7):917-22. PubMed ID: 17617038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 assay (bDNA).
    Tong CY; Hollingsworth RC; Williams H; Irving WL; Gilmore IT
    J Med Virol; 1998 Jul; 55(3):191-6. PubMed ID: 9624605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the quantitative HCV NASBA assay.
    Damen M; Sillekens P; Cuypers HT; Frantzen I; Melsert R
    J Virol Methods; 1999 Sep; 82(1):45-54. PubMed ID: 10507412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and quantitation of HCV RNA using real-time PCR after automated sample processing.
    Sandres-Sauné K; Abravanel F; Nicot F; Peron JM; Alric L; Boineau J; Pasquier C; Izopet J
    J Med Virol; 2007 Dec; 79(12):1821-6. PubMed ID: 17935166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.